排序方式: 共有51条查询结果,搜索用时 0 毫秒
51.
We extend the approach of finding effective sample size for a typical phase II clinical trial having efficacy and toxicity as two components of the response vector. The case of binary efficacy and binary toxicity is illustrated under Dirichlet and multivariate T priors. 相似文献